BIBS39

  Cat. No.:  DC9670   Featured
Chemical Structure
133085-33-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
Cas No.: 133085-33-3
Chemical Name: BIBS39
Synonyms: [1,1'-Biphenyl]-2-carboxylicacid,4'-[[2-butyl-6-[[(cyclohexylamino)carbonyl]amino]-1H-benzimidazol-1-yl]methyl]-;[1,1'-Biphenyl]-2-carboxylicacid,4'-[[2-butyl-6-[[(cyclohexylamino)carbonyl]amino]-1H-benzimid...;2-[4-[[2-butyl-6-(cyclohexylcarbamoylamino)benzimidazol-1-yl]methyl]phenyl]benzoic acid;BIBS 39;(1,1'-Biphenyl)-2-carboxylic acid, 4'-((2-butyl-6-(((cyclohexylamino)carbonyl)amino)-1H-benzimidazo-1-yl)methyl)-;4'-((2-Butyl-6-(((cyclohexylamino)carbonyl)amino)-1H-benzimidazo-1-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid;4'-((2-n-Butyl-6-cyclohexylaminocarbonylaminobenzimidazole-1-yl)methyl)biphenyl-2-carboxylic acid;4'-({2-butyl-6-[(cyclohexylcarbamoyl)amino]-1H-benzimidazol-1-yl}methyl)biphenyl-2-carboxylic a;BIBS-39
SMILES: O=C(C1=CC=CC=C1C2=CC=C(CN3C4=CC(NC(NC5CCCCC5)=O)=CC=C4N=C3CCCC)C=C2)O
Formula: C32H36N4O3
M.Wt: 524.65324
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC8901 Azilsartan medoxomil Azilsartan medoxomil(TAK 491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of  0.62 nM, which used in the treatment of adults with essential hypertension.
DC10869 Olodanrigan(EMA401) EMA401(Olodanrigan) is a highly selective AT2R antagonist, inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons.
DC9670 BIBS39 BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
X